VolitionRX (VNRX) Rating Maintained as Buy by D. Boral Capital

Analyst Jason Kolbert from D. Boral Capital has maintained a ‘Buy’ rating for VolitionRX (VNRX) with an unchanged price target of $3.00 USD. This reiteration reflects consistent confidence in the company’s prospects, with historical ratings showing a steady ‘Buy’ status. The average target price from 5 analysts is $2.06, suggesting a significant upside of 984.21% from the current price, while GuruFocus estimates a fair value of $1.40 for VNRX.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin